Livforsakringsbolaget Skandia’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,800	Closed	-$1.18M	–	677
2015 Q1	$1.18M	Buy	+6,800	New	+$998K	0.06%	407

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Livforsakringsbolaget Skandia's SLXP Position: Q2 2015 in Review

Livforsakringsbolaget Skandia sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,800 shares — an estimated $1.18M sold.

Livforsakringsbolaget Skandia first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $1.18M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Livforsakringsbolaget Skandia reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 6,800 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.18M.
Livforsakringsbolaget Skandia first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Livforsakringsbolaget Skandia's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.18M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2015, filed 16 Jul 2015.